Domestic markets had yet another week of breaching all-time highs on buying in heavyweight stocks in the run-up to the Budget. Looking forward, analysts say the market direction will largely be influenced by upcoming earnings reports and discussions on the Union Budget. Global market trends, particularly the robust performance of US markets, will also be closely watched. In this setup, here are 5 stocks that you can consider buying for robust returns in the short term.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026